Cargando…
DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
Death-associated protein kinase 1 (DAPK1), a Ca(2+)/calmodulin (CaM)-dependent serine/threonine protein kinase, plays important roles in diverse apoptosis pathways not only in tumor suppression but also in neuronal cell death. The requirement of DAPK1 catalytic activity for its proposed cell functio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509806/ https://www.ncbi.nlm.nih.gov/pubmed/27447806 http://dx.doi.org/10.1007/s12035-016-0008-y |
_version_ | 1783250079207915520 |
---|---|
author | Wang, Shan Shi, Xiangde Li, Hao Pang, Pei Pei, Lei Shen, Huiyong Lu, Youming |
author_facet | Wang, Shan Shi, Xiangde Li, Hao Pang, Pei Pei, Lei Shen, Huiyong Lu, Youming |
author_sort | Wang, Shan |
collection | PubMed |
description | Death-associated protein kinase 1 (DAPK1), a Ca(2+)/calmodulin (CaM)-dependent serine/threonine protein kinase, plays important roles in diverse apoptosis pathways not only in tumor suppression but also in neuronal cell death. The requirement of DAPK1 catalytic activity for its proposed cell functions and the elevation of catalytic activity of DAPK1 in injured neurons in models of neurological diseases, such as ischemia and epilepsy, validate that DAPK1 can be taken as a potential therapeutic target in these diseases. Recent studies show that DAPK1-NR2B, DAPK1-DANGER, DAPK1-p53, and DAPK1-Tau are currently known pathways in stroke-induced cell death, and blocking these cascades in an acute treatment effectively reduces neuronal loss. In this review, we focus on the role of DAPK1 in neuronal cell death after stroke. We hope to provide exhaustive summaries of relevant studies on DAPK1 signals involved in stroke damage. Therefore, disrupting DAPK1-relevant cell death pathway could be considered as a promising therapeutic approach in stroke. |
format | Online Article Text |
id | pubmed-5509806 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-55098062017-07-28 DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies Wang, Shan Shi, Xiangde Li, Hao Pang, Pei Pei, Lei Shen, Huiyong Lu, Youming Mol Neurobiol Article Death-associated protein kinase 1 (DAPK1), a Ca(2+)/calmodulin (CaM)-dependent serine/threonine protein kinase, plays important roles in diverse apoptosis pathways not only in tumor suppression but also in neuronal cell death. The requirement of DAPK1 catalytic activity for its proposed cell functions and the elevation of catalytic activity of DAPK1 in injured neurons in models of neurological diseases, such as ischemia and epilepsy, validate that DAPK1 can be taken as a potential therapeutic target in these diseases. Recent studies show that DAPK1-NR2B, DAPK1-DANGER, DAPK1-p53, and DAPK1-Tau are currently known pathways in stroke-induced cell death, and blocking these cascades in an acute treatment effectively reduces neuronal loss. In this review, we focus on the role of DAPK1 in neuronal cell death after stroke. We hope to provide exhaustive summaries of relevant studies on DAPK1 signals involved in stroke damage. Therefore, disrupting DAPK1-relevant cell death pathway could be considered as a promising therapeutic approach in stroke. Springer US 2016-07-22 2017 /pmc/articles/PMC5509806/ /pubmed/27447806 http://dx.doi.org/10.1007/s12035-016-0008-y Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Wang, Shan Shi, Xiangde Li, Hao Pang, Pei Pei, Lei Shen, Huiyong Lu, Youming DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies |
title | DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies |
title_full | DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies |
title_fullStr | DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies |
title_full_unstemmed | DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies |
title_short | DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies |
title_sort | dapk1 signaling pathways in stroke: from mechanisms to therapies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509806/ https://www.ncbi.nlm.nih.gov/pubmed/27447806 http://dx.doi.org/10.1007/s12035-016-0008-y |
work_keys_str_mv | AT wangshan dapk1signalingpathwaysinstrokefrommechanismstotherapies AT shixiangde dapk1signalingpathwaysinstrokefrommechanismstotherapies AT lihao dapk1signalingpathwaysinstrokefrommechanismstotherapies AT pangpei dapk1signalingpathwaysinstrokefrommechanismstotherapies AT peilei dapk1signalingpathwaysinstrokefrommechanismstotherapies AT shenhuiyong dapk1signalingpathwaysinstrokefrommechanismstotherapies AT luyouming dapk1signalingpathwaysinstrokefrommechanismstotherapies |